Access the full text.
Sign up today, get DeepDyve free for 14 days.
HT Lynch, A Chapelle (2003)
Genomic medicine: Hereditary colon cancer.N Engl J Med, 348
HT Lynch, S Lanspa, T Smyrk (1991)
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II): genetics, pathology, natural history, and cancer control, part I.Cancer Genet Cytogenet, 53
SM Lipkin, LS Rozek, G Rennert (2004)
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.Nat Genet, 36
CM Suter, DIK Martin, RL Ward (2004)
Germline epimutation of MLH1 in individuals with multiple cancers.Nat Genet, 36
JP Mecklin (1987)
Frequency of hereditary colorectal carcinoma.Gastroenterology, 93
la Chapelle A de (2004)
Genetic predisposition to colorectal cancer.Nat Rev Cancer, 4
RG Cotton, CR Scriver (1998)
Proof of ?disease causing? mutation.Hum Mut, 12
PJ Westlake, HE Bryant, SA Huchcroft, LR Sutherland (1991)
Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta.Dig Dis Sci, 36
HFA Vasen, P Watson, J-P Mecklin, HT Lynch, ICG-HNPCC the (1999)
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC.Gastroenterology, 116
P Peltomäki, HFA Vasen, International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer The (1997)
Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study.Gastroenterology, 113
Leon M Ponz, R Sassatelli, P Benatti, L Roncucci (1993)
Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registryCancer, 71
LA Aaltonen, R Sankila, J-P Mecklin (1994)
A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden.Cancer Det Prev, 18
SJ Laken, GM Petersen, SB Gruber (1997)
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.Nat Genet, 17
LA Aaltonen, R Salovaara, P Kristo (1998)
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.N Engl J Med, 338
M. Ravnik-Glavac, U Potocnik, D Glavac (2000)
Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population.J Med Genet, 37
A Chapelle (2002)
Editorial.Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry: The jury is still out. J Clin Oncol, 20
B Pasche, V Kaklamani, N Hou (2004)
TBFBR1*6A and cancer: A meta-analysis of 12 case-control studies.J Clin Oncol, 22
R Salovaara, A Loukola, P Kristo (2000)
Population-based molecular detection of hereditary nonpolyposis colorectal cancer.J Clin Oncol, 18
CA Adebamowo, O Adeyi, R Pyatt (2000)
Case report on hereditary non-polyposis colon cancer (HNPCC) in Nigeria.Afr J Med Med Sci, 29
NM Lindor, LJ Burgart, O Leontovich (2002)
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.J Clin Oncol, 20
CR Boland, SN Thibodeau, SR Hamilton (1998)
A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer.Cancer Res, 58
GL Wiesner, D Daley, S Lewis (2003)
A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2.PNAS, 100
DG Evans, CL Wu, S Walsh (2001)
Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.J Natl Cancer Inst, 93
Leon M Ponz, R Sassatelli, C Sacchetti, G Zanghieri, A Scalmati, L Roncucci (1989)
Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry.Cancer Res, 49
JP Terdiman, TR Levin, BA Allen (2002)
Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: High-risk clinic versus population-based registry.Gastroenterology, 122
JP Terdiman (2001)
HNPCC: An uncommon but important diagnosis.Gastroenterology, 121
F Kee, BJ Collins (1991)
How prevalent is cancer family syndrome?Gut, 32
S Syngal, EA Fox, C Li (1999)
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer. Implications for clinical predisposition testingJAMA, 282
JP Terdiman, JR Gum, PG Conrad (2001)
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.Gastroenterology, 120
PJ Goodfellow, BM Buttin, TJ Herzog (2003)
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.Proc Natl Acad Sci USA, 100
H Nakagawa, JC Lockman, WL Frankel (2004)
Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein but paralogous genes obscure mutation detection and interpretation.Cancer Res, 64
HJ Järvinen, M Aarnio, H Mustonen (2000)
Controlled 15-year trial on screening for colorectal cancer in hereditary nonpolyposis colorectal cancer families.Gastroenterology, 118
A Percesepe, F Borghi, M Menigatti (2001)
Molecular screening for hereditary nonpolyposis colorectal cancer: A prospective, population-based study.J Clin Oncol, 19
JP Mecklin, HJ Jarvinen, A Hakkiluoto (1995)
Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in FinlandDis Colon Rectum, 38
JM Cunningham, C-Y Kim, ER Christensen (2001)
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.Am J Hum Genet, 69
HFA Vasen, J-P Mecklin, PM Khan, HT Lynch (1991)
The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer.Dis Colon Rectum, 34
WS Samowitz, K Curtin, HH Lin (2001)
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.Gastroenterology, 121
Lynch syndrome (LS) here is defined as carriership of a deleterious mismatch repair (MMR) gene mutation. By screening for MMR gene mutations in unselected colorectal or endometrial cancer patients, it was found that the prevalence of LS in colorectal and endometrial cancer patients is 1–3%. On extrapolation to the entire population, the incidence of LS is between 1:2000 and 1:660. As all screening methods are less than 100% sensitive, the above figures are underestimates.
Familial Cancer – Springer Journals
Published: Nov 3, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.